We used GEPIA2 to obtain a panoramic perspective of the expression of all the MAL-family genes in a list of 21 cancers that included BLCA, BRCA, CESC, COAD, ESCA, HNSC, kidney chromophobe carcinoma (KICH), kidney renal clear cell carcinoma (KIRC), kidney renal papillary cell carcinoma (KIRP), LICH, LUAD, LUSC, OV, PAAD, prostate adenocarcinoma (PRAD), READ, sarcoma (SARC), SCKM, STAD, thymoma (THYM), and UCEC (Figure 4 and Table S1). This evidence concerns the gene MAL and thymoma.